| 5 | 1/1 | 返回列表 |
| 查看: 3072 | 回復: 10 | |||
| 當前只顯示滿足指定條件的回帖,點擊這里查看本話題的所有回帖 | |||
[求助]
accept with major revision 但意見不多
|
|||
|
Dear Dr Peng, I regret to inform you that your work can be reconsidered for publication only with extensive revisions to your manuscript. The reviewers' advice on the necessary revisions and their comments are appended below. If you are willing to undertake the required amendments, please submit a point by point response listing your changes or justifications to the reviewers' comments when you submit the revised manuscript. With warm regards, Toshio Kitamura Reviewers' comments: A Editorial Board This study, which is carefully performed, is an interesting one. Both reviewers recognized some merit in this paper. Please carefully respond all concerns raised by the reviewers. I have one minor concern Regarding statistic p values, the authors should described them as more accurate number (for example <0.001) instead of 0.00. Reviewer #1: This paper describes the long-term effects of laparoscopic splenectomy (LS) for patients with chronic immune thrombocytopenia (ITP). They also tried to determine the predictive factors for promising hematological outcomes. Along with the advancement in some new drugs including rituximab and thrombopoietin receptor agonists, it is important to re-examine and analyze the long-term effects of LS and the predictive factors for good outcomes. Major issues 1. They retrospectively analyzed the data in 92 patients who underwent LS for chronic ITP. Their remission rate (76.1%) is relatively favorable and indicated that LS is still one of the treatment options for chronic ITP even in an era of new drugs. 2. Using multivariate logistic regression analysis, they showed that only the platelet counts on postoperative months 3 (POM3) was a significant independent prognostic factor for long-time response to LS. This information is also useful to estimate the long-time response for each patient. 3. The authors previously reported about LS for ITP patients (ref 11, Int J Hematol 94:533-538) . In this paper, they analysed 10 ITP patients who underwent LS because of severe thrombocytopenia, from April 2006 to Jan 2011. They have to make clear whether these 10 patients were overlapped with 92 (from Nov 2006 to Aug 2012) patients in the current report or not. 4. They mentioned that one patient has died of severe pulmonary infection after LS on POD 5. I want to know whether this patient was suffered by overwhelming postsplenectomy infection (OPSI). It is also interesting to know whether these patients were given pneumococcal vaccine around LS in their institute. Minor issues 1. In Table 2, they use abbreviated words "RG" and "NG". They should indicate what these abbreviations stand for. Reviewer #2: The authors described the clinical research entitled predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia. In this paper, they clearly demonstrated that platelet count on POM3 was significant independent predictor of long-term favorable outcome. Their conclusions are almost acceptable, however, several questions are raised up as below. 1) Several investigators already reported that young patients showed higher CR responses of splenectomy than those in elderly patients. However, CR rate in this paper was thought to be lower (53.3 %) than expected. 2) It was reported that the good response to IVIG might be available for predictor of successful splenectomy. Did you check this phenomenon in your study? 3) The importance of platelet raise after splenectomy was already well known in hematologists. Some papers reported POM 1 was available as predictable indicator.However, you mentioned the POM3 was significant, not POM 1. You should explain the reason on 求助。有戲沒???徹夜難眠55555555555 |
榮譽版主 (文學泰斗)
還沒想好
![]() |
專家經驗: +14 |

木蟲 (正式寫手)

至尊木蟲 (知名作家)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿211院校 344分 東北農業(yè)大學生物學學碩,求調劑 +5 | 丶風雪夜歸人丶 2026-03-26 | 8/400 |
|
|---|---|---|---|---|
|
[考研] 一志愿北化085600材料專碩275|有文章專利|求調劑 +3 | Micky11223 2026-03-25 | 3/150 |
|
|
[考研] 085601 材料工程 313分 求調劑 +5 | Ong3 2026-03-27 | 5/250 |
|
|
[考研] 求調劑 +3 | 劉柯@ 2026-03-24 | 4/200 |
|
|
[考研] 考研調劑 +9 | 小蠟新筆 2026-03-26 | 9/450 |
|
|
[論文投稿] Journal of Mechanical Science and Technology +3 | Russ_ss 2026-03-25 | 5/250 |
|
|
[考研] 341求調劑 +7 | 青檸檬1 2026-03-26 | 7/350 |
|
|
[考研] 321求調劑 +6 | wasdssaa 2026-03-26 | 6/300 |
|
|
[考研] 求調劑 +5 | 蘆lty 2026-03-25 | 6/300 |
|
|
[考研] 321求調劑 +5 | 材料cailiao 2026-03-21 | 5/250 |
|
|
[考研]
|
y7czhao 2026-03-26 | 8/400 |
|
|
[考研] 生物學 296 求調劑 +4 | 朵朵- 2026-03-26 | 6/300 |
|
|
[考研] 一志愿北京化工大學材料與化工(085600)296求調劑 +9 | 稻妻小編 2026-03-26 | 9/450 |
|
|
[考研] 0856求調劑 +8 | zhn03 2026-03-25 | 9/450 |
|
|
[考研] 考研調劑 +6 | 來好運來來來 2026-03-21 | 7/350 |
|
|
[考研] 293求調劑 +7 | 加一一九 2026-03-24 | 7/350 |
|
|
[有機交流]
20+3
|
FENGSHUJEI 2026-03-23 | 5/250 |
|
|
[考研] 277分求調劑,跨調材料 +3 | 考研調劑lxh 2026-03-24 | 3/150 |
|
|
[考研] 材料/農業(yè)專業(yè),07/08開頭均可,過線就行 +3 | 呵唔哦豁 2026-03-23 | 4/200 |
|
|
[考研] 275求調劑 +6 | shansx 2026-03-22 | 8/400 |
|